Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
99296-6 Checklist of nonverbal pain indicators at rest panel - ^Patient Pt - CNPI &nbsp; ACTIVE Checklist of nonverbal pain indicators at rest panel [CNPI] &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CNPI &nbsp; 99296-6 &nbsp; CNPI &nbsp; &nbsp; Subset &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; CNPI at rest panel; Nonverb pain ind; Pan; Panl; Pnl; Point in time; Random; Resting; Survey; SURVEY.CNPI 2.72 2.72 &nbsp; Organizer &nbsp; &nbsp; Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99297-4 Nonverbal vocal complaints while at rest Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Nonverbal vocal complaints while at rest &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CNPI &nbsp; 99297-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Nonverb vocal complaints while at rest; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Survey; SURVEY.CNPI 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99298-2 Facial grimaces or winces while at rest Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Facial grimaces or winces while at rest &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CNPI &nbsp; 99298-2 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Grimaces/winces while at rest; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Survey; SURVEY.CNPI 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99299-0 Bracing while at rest Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Bracing while at rest &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CNPI &nbsp; 99299-0 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Survey; SURVEY.CNPI 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
993-6 D little o super little a Ab PrThr Ser/Plas Pt Ord &nbsp; &nbsp; ACTIVE Do sup(a) Ab [Presence] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 993-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Do sup(a) Ab SerPl Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; D (little o) (little a); Dextro; Do sup(a); Do^a; Dombrock; Dombrock Blood Group System; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
9930-9 Q wave depth.lead III Elpot Heart Pt Qn EKG &nbsp; ACTIVE Q wave depth in lead III &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9930-9 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Q wave Dpth L-III &nbsp; &nbsp; &nbsp; Y &nbsp; 3; Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth Lead; Q wave Dpth L-III; QNT; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
99300-6 Restlessness while at rest Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Restlessness while at rest &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CNPI &nbsp; 99300-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Survey; SURVEY.CNPI 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99301-4 Rubbing while at rest Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Rubbing while at rest &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CNPI &nbsp; 99301-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Survey; SURVEY.CNPI 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99302-2 Verbal complaints while at rest Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Verbal complaints while at rest &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CNPI &nbsp; 99302-2 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Survey; SURVEY.CNPI 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99303-0 At rest score Score ^Patient Pt Qn CNPI &nbsp; ACTIVE At rest score [CNPI] &nbsp; ADD DefinitionDescription &nbsp; &nbsp; score &nbsp; Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CNPI &nbsp; 99303-0 &nbsp; CNPI &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Point in time; QNT; Quan; Quant; Quantitative; Random; Resting; Scale; Survey; SURVEY.CNPI 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission &nbsp; &nbsp; {score} &nbsp; &nbsp; &nbsp; 0
99304-8 Total score Score ^Patient Pt Qn CNPI &nbsp; ACTIVE Total score [CNPI] &nbsp; ADD DefinitionDescription &nbsp; &nbsp; score &nbsp; Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CNPI &nbsp; 99304-8 &nbsp; CNPI &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.CNPI; Tot; Totl 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission &nbsp; &nbsp; {score} &nbsp; &nbsp; &nbsp; 0
99305-5 Checklist of nonverbal pain indicators assessment Imp ^Patient Pt Nom CNPI &nbsp; ACTIVE Checklist of nonverbal pain indicators assessment [CNPI] &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CNPI &nbsp; 99305-5 &nbsp; CNPI &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; CNPI assessment; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Nonverb pain ind; Point in time; Random; Survey; SURVEY.CNPI 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99306-3 Choriogonadotropin.beta subunit heterophile Ab interference panel - Ser Pt - &nbsp; &nbsp; ACTIVE Choriogonadotropin.beta subunit heterophile Ab interference panel - Serum &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CHEM &nbsp; 99306-3 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 B-HCG heterph Ab intrf Pnl Ser &nbsp; &nbsp; &nbsp; N &nbsp; B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; B-HCG heterph Ab intrf; B-HCG heterph Ab intrf Pnl; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; Epstein-Barr virus; HCG; Hetero; Heteroph; Hetr; Human chorionic gonadotropin; Mono screen; Mono slide; Mono spot; Mono test; Mononucleosis screen; Mononucleosis test; Monospot; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Serum; SR; Tumor marker 2.72 2.72 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99307-1 Choriogonadotropin.beta subunit heterophile Ab interference PrThr Ser Pt Ord &nbsp; &nbsp; ACTIVE Choriogonadotropin.beta subunit heterophile Ab interference [Presence] in Serum &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99307-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 B-HCG heterph Ab intrf Ser Ql &nbsp; &nbsp; &nbsp; N &nbsp; B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; B-HCG heterph Ab intrf; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; Epstein-Barr virus; HCG; Hetero; Heteroph; Hetr; Human chorionic gonadotropin; Mono screen; Mono slide; Mono spot; Mono test; Mononucleosis screen; Mononucleosis test; Monospot; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Tumor marker 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99308-9 Acid alpha glucosidase cross-reactive immunologic material (CRIM) PrThr WBC Pt Ord IB &nbsp; ACTIVE Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Leukocytes by Immunoblot &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99308-9 &nbsp; IB &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 AAG CRIM WBC Ql IB &nbsp; &nbsp; &nbsp; N &nbsp; AAG CRIM; Acd; Acid A-Glucosidase; Acid maltase; Acids; Alfa; Alpha galactosidase; Alpha-1,4-glucosidase; Blt; Chemistry; CRIM; GAA; Glucoinvertase; Glucosidosucrase; Immune blot; Immunobl; Immunoblot; Immunol; Leukocytes; Maltase; Maltase-glucoamylase; Ordinal; Point in time; Pompe disease; PR; QL; Qual; Qualitative; Random; Reac; React; RIBA; Screen; WB; WBCs; WBLOT; West blot; West blt; Western blot; White blood cells 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99309-7 Acid alpha glucosidase cross-reactive immunologic material (CRIM) PrThr Tissue Pt Ord IB &nbsp; ACTIVE Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Tissue by Immunoblot &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99309-7 &nbsp; IB &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 AAG CRIM tiss Ql IB &nbsp; &nbsp; &nbsp; N &nbsp; AAG CRIM; Acd; Acid A-Glucosidase; Acid maltase; Acids; Alfa; Alpha galactosidase; Alpha-1,4-glucosidase; Blt; Chemistry; CRIM; GAA; Glucoinvertase; Glucosidosucrase; Immune blot; Immunobl; Immunoblot; Immunol; Maltase; Maltase-glucoamylase; Ordinal; Point in time; Pompe disease; PR; QL; Qual; Qualitative; Random; Reac; React; RIBA; Screen; WB; WBLOT; West blot; West blt; Western blot 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
9931-7 Q wave depth.lead V1 Elpot Heart Pt Qn EKG &nbsp; ACTIVE Q wave depth in lead V1 &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9931-7 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Q wave Dpth L-V1 &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth Lead; Q wave Dpth L-V1; QNT; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
99310-5 Total score^^adjusted for age Score ^Patient Pt Qn &nbsp; &nbsp; ACTIVE Total score age adjusted &nbsp; ADD DefinitionDescription &nbsp; &nbsp; Score &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CLIN.RISK &nbsp; 99310-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Total score age-adj &nbsp; &nbsp; &nbsp; N &nbsp; adj; age-adj; CLIN; CLIN.RISK; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Tot; Total score - age adjusted; Totl 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {score} &nbsp; &nbsp; &nbsp; 0
99311-3 Seizure onset Type ^Patient Pt Nom &nbsp; &nbsp; ACTIVE Seizure onset &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; H&P.HX &nbsp; 99311-3 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Seizure onset &nbsp; &nbsp; &nbsp; N &nbsp; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99312-1 Seizure frequency Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Seizure frequency &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; H&P.HX &nbsp; 99312-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Seizure frequency &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99313-9 Time since last seizure Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Time since last seizure &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; H&P.HX &nbsp; 99313-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Time since last seizure &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Past; Point in time; QL; Qual; Qualitative; Random; Screen 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99314-7 SARS coronavirus 2 RdRp gene mutation detected Prid XXX Pt Nom Molgen &nbsp; ACTIVE SARS-CoV-2 (COVID-19) RdRp gene mutation detected [Identifier] in Specimen by Molecular genetics method &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 99314-7 &nbsp; Molgen &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 SARS-CoV-2 RdRp mut Spec &nbsp; &nbsp; &nbsp; N &nbsp; 2019 Novel Coronavirus; 2019-nCoV; Corona virus; COVID19; COVID-19; ID; Identity or presence; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Molecular genetics; Mut; Mutations; Nominal; Other; PCR; PH; Point in time; Public Health; PublicHealth; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 RdRp; SARS-CoV-2 RdRp mut; Severe Acute Respiratory Syndrome; Spec; To be specified in another part of the message; Unspecified; Viral Pneumonias; Wuhan coronavirus 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99315-4 OASIS E - Intervention synopsis - DC, TRN - ^Patient RptPeriod - CMS Assessment &nbsp; ACTIVE OASIS E - Intervention synopsis - DC, TRN during assessment period [CMS Assessment] &nbsp; PANEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CMS &nbsp; 99315-4 &nbsp; CMS Assessment &nbsp; &nbsp; Subset &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.8 2.72 &nbsp; Organizer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; 0
9932-5 Q wave depth.lead V2 Elpot Heart Pt Qn EKG &nbsp; ACTIVE Q wave depth in lead V2 &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9932-5 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Q wave Dpth L-V2 &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth Lead; Q wave Dpth L-V2; QNT; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
9933-3 Q wave depth.lead V3 Elpot Heart Pt Qn EKG &nbsp; ACTIVE Q wave depth in lead V3 &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9933-3 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Q wave Dpth L-V3 &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth Lead; Q wave Dpth L-V3; QNT; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
108,248 results found